# Mereo BioPharma Group plc: Form 8-K, filed Aug 19, 2026

- Company: [Mereo BioPharma Group plc](/companies/mreo.md) (CIK 1719714)
- Form: 8-K
- Filed: 2026-08-19
- Accepted by EDGAR: Aug 19, 2026, 07:52 ET
- Period: 2026-08-18
- Accession: 0001193125-26-356168
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/mreo-20260217.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/mreo-20260217.htm

Filed Aug 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-356168. Last ingested by Listed: Nov 9, 2026, 18:01 ET. No prices; not investment advice.
